论文部分内容阅读
目的观察奥扎格雷钠联合低分子肝素钙治疗急性脑梗死的临床疗效。方法将92例住院急性脑梗死患者,分为两组进行治疗,对照组给予奥扎格雷钠注射液静脉滴注;治疗组在对照组基础上给予低分子肝素钙皮下注射。治疗结束后比较两组患者的临床疗效。结果治疗组总有效率为93.5%,对照组总有效率为80.4%,治疗组临床疗效明显高于对照组,二者相比具有显著性差异(P<0.05)。结论奥扎格雷钠联合低分子肝素钙治疗急性脑梗塞可明显提高临床疗效。
Objective To observe the clinical efficacy of sodium ozagrel combined with low molecular weight heparin in the treatment of acute cerebral infarction. Methods 92 hospitalized patients with acute cerebral infarction were divided into two groups, and the control group received intravenous infusion of ozagrel sodium. The treatment group was injected subcutaneously with low molecular weight heparin on the basis of the control group. After treatment, the clinical efficacy of the two groups was compared. Results The total effective rate was 93.5% in the treatment group and 80.4% in the control group. The clinical efficacy of the treatment group was significantly higher than that of the control group (P <0.05). Conclusion Ozagrel sodium combined with low molecular weight heparin in the treatment of acute cerebral infarction can significantly improve the clinical efficacy.